Impacts of N-Butylphthalide on Expression of Growth Factors in Rats with Focal Cerebral Ischemia

Overview

Journal Bosn J Basic Med Sci

Specialty General Medicine

Date 2016 Jan 17

PMID 26773175

Citations 5

Authors

Yan Jiang

Leyu Sun

Xiaoyan Xuan

Jianping Wang

Affiliations

Soon will be listed here.

Abstract

This study investigates the impacts of n-butylphthalide (NBP) on the expression of vascular endothelial growth factor (VEGF) and transforming growth factor-β1 (TGF-β1) in rats with focal cerebral ischemia. The thread embolization method was used to prepare the rat model of cerebral ischemia-reperfusion (CIR). The animals were divided into a sham operation group, a model control group and NBP treatment group. The NBP group was orally administered 25 mg/kg NBP twice a day after the surgery. The immunohistochemistry and reverse transcription-polymerase chain reaction were performed to observe the protein and mRNA expressions of VEGF and TGF-β 16 hours, 1 day and 2 days after inducing CIR. The mRNA and protein expressions of VEGF and TGF-β1 in the model control group and the NBP treatment group were all increased after CIR, and those of the NBP treatment group at each post-CIR time point were higher than the model control group (p < 0.01). After CIR, the expressions of VEGF and TGF-β1 increased, suggesting that VEGF and TGF-β1 exhibited protective effects towards the ischemic brain injuries, and that NBP could upregulate the expressions of VEGF and TGF-β1 in the peri-infarcted area, thus possibly protecting the ischemic brain tissues through this mechanism.

Citing Articles

Butylphthalide Combined With Conventional Treatment Attenuates MMP-9 Levels and Increases VEGF Levels in Patients With Stroke: A Prospective Cohort Study.

Xiong Y, Liu J, Xu Y, Xie S, Zhou X, Cheng S Front Neurol. 2022; 12:686199.

PMID: 34987460 PMC: 8720749. DOI: 10.3389/fneur.2021.686199.

DL-3-n-butylphthalide improves cerebral hypoperfusion in patients with large cerebral atherosclerotic stenosis: a single-center, randomized, double-blind, placebo-controlled study.

Chen D, Yin Y, Shi J, Yang F, Wang K, Zhao F BMC Neurol. 2020; 20(1):212.

PMID: 32456617 PMC: 7251861. DOI: 10.1186/s12883-020-01801-5.

Application and prospects of butylphthalide for the treatment of neurologic diseases.

Chen X, Qiu K, Liu H, He Q, Bai J, Lu W Chin Med J (Engl). 2019; 132(12):1467-1477.

PMID: 31205106 PMC: 6629339. DOI: 10.1097/CM9.0000000000000289.

Vascular endothelial growth factor (VEGF)-related single nucleotide polymorphisms rs10738760 and rs6921438 are not associated with diabetic retinopathy (DR) in Slovenian patients with type 2 diabetes mellitus (T2DM).

Terzic R, Cilensek I, Zorc Pleskovic R, Mankoc S, Milutinovic A Bosn J Basic Med Sci. 2017; 17(4):328-332.

PMID: 29055125 PMC: 5708904. DOI: 10.17305/bjbms.2017.2068.

Dl-3-n-butylphthalide attenuates acute inflammatory activation in rats with spinal cord injury by inhibiting microglial TLR4/NF-κB signalling.

He Z, Zhou Y, Lin L, Wang Q, Khor S, Mao Y J Cell Mol Med. 2017; 21(11):3010-3022.

PMID: 28842949 PMC: 5661102. DOI: 10.1111/jcmm.13212.

References

Goumans M, Lebrin F, Valdimarsdottir G . Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways. Trends Cardiovasc Med. 2003; 13(7):301-7. DOI: 10.1016/s1050-1738(03)00142-7. View

Ferrara N, Henzel W . Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989; 161(2):851-8. DOI: 10.1016/0006-291x(89)92678-8. View

Longa E, Weinstein P, Carlson S, Cummins R . Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989; 20(1):84-91. DOI: 10.1161/01.str.20.1.84. View

Hansen T, Moss A, Brindle N . Vascular endothelial growth factor and angiopoietins in neurovascular regeneration and protection following stroke. Curr Neurovasc Res. 2008; 5(4):236-45. DOI: 10.2174/156720208786413433. View

Zausinger S, Hungerhuber E, Baethmann A, Reulen H, Schmid-Elsaesser R . Neurological impairment in rats after transient middle cerebral artery occlusion: a comparative study under various treatment paradigms. Brain Res. 2000; 863(1-2):94-105. DOI: 10.1016/s0006-8993(00)02100-4. View

Thored P, Wood J, Arvidsson A, Cammenga J, Kokaia Z, Lindvall O . Long-term neuroblast migration along blood vessels in an area with transient angiogenesis and increased vascularization after stroke. Stroke. 2007; 38(11):3032-9. DOI: 10.1161/STROKEAHA.107.488445. View

Tuor U, Morgunov M, Sule M, Qiao M, Clark D, Rushforth D . Cellular correlates of longitudinal diffusion tensor imaging of axonal degeneration following hypoxic-ischemic cerebral infarction in neonatal rats. Neuroimage Clin. 2014; 6:32-42. PMC: 4215526. DOI: 10.1016/j.nicl.2014.08.003. View

Tang Y, Wang J, Lin X, Wang L, Shao B, Jin K . Neural stem cell protects aged rat brain from ischemia-reperfusion injury through neurogenesis and angiogenesis. J Cereb Blood Flow Metab. 2014; 34(7):1138-47. PMC: 4083376. DOI: 10.1038/jcbfm.2014.61. View

Cui W, Li W, Han R, Mak S, Zhang H, Hu S . PI3-K/Akt and ERK pathways activated by VEGF play opposite roles in MPP+-induced neuronal apoptosis. Neurochem Int. 2011; 59(6):945-53. DOI: 10.1016/j.neuint.2011.07.005. View

10.

Kim Y, Ryu J, Lee Y, Han H . Fibronectin synthesis by high glucose level mediated proliferation of mouse embryonic stem cells: Involvement of ANG II and TGF-beta1. J Cell Physiol. 2010; 223(2):397-407. DOI: 10.1002/jcp.22048. View

11.

Ponce C, Chauffaille M, Ihara S, Silva M . Increased angiogenesis in primary myelofibrosis: latent transforming growth factor-β as a possible angiogenic factor. Rev Bras Hematol Hemoter. 2014; 36(5):322-8. PMC: 4318371. DOI: 10.1016/j.bjhh.2014.07.010. View

12.

Li Y, Lu Z, Keogh C, Yu S, Wei L . Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice. J Cereb Blood Flow Metab. 2006; 27(5):1043-54. DOI: 10.1038/sj.jcbfm.9600417. View

13.

Brionne T, Tesseur I, Masliah E, Wyss-Coray T . Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron. 2003; 40(6):1133-45. DOI: 10.1016/s0896-6273(03)00766-9. View

14.

Manoonkitiwongsa P, Schultz R, McCreery D, Whitter E, Lyden P . Neuroprotection of ischemic brain by vascular endothelial growth factor is critically dependent on proper dosage and may be compromised by angiogenesis. J Cereb Blood Flow Metab. 2004; 24(6):693-702. DOI: 10.1097/01.WCB.0000126236.54306.21. View

15.

Yang Z, Qiu M, Zhang L, Lu S, Huang Y, Sun F . Role of vascular endothelial growth factor in neuronal DNA damage and repair in rat brain following a transient cerebral ischemia. J Neurosci Res. 2002; 70(2):140-9. DOI: 10.1002/jnr.10380. View

16.

Greenberg D, Jin K . Vascular endothelial growth factors (VEGFs) and stroke. Cell Mol Life Sci. 2013; 70(10):1753-61. PMC: 3634892. DOI: 10.1007/s00018-013-1282-8. View

17.

Won S, Lee J, Wali B, Stein D, Sayeed I . Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway. J Cereb Blood Flow Metab. 2013; 34(1):72-80. PMC: 3887344. DOI: 10.1038/jcbfm.2013.163. View

18.

Shih S, Ju M, Liu N, Mo J, Ney J, Smith L . Transforming growth factor beta1 induction of vascular endothelial growth factor receptor 1: mechanism of pericyte-induced vascular survival in vivo. Proc Natl Acad Sci U S A. 2003; 100(26):15859-64. PMC: 307658. DOI: 10.1073/pnas.2136855100. View

19.

Ng J . TGF-beta signals regulate axonal development through distinct Smad-independent mechanisms. Development. 2008; 135(24):4025-35. PMC: 2628568. DOI: 10.1242/dev.028209. View

20.

Sun J, Zhou W, Sha B, Yang Y . Ischemia induced neural stem cell proliferation and differentiation in neonatal rat involved vascular endothelial growth factor and transforming growth factor-beta pathways. Brain Dev. 2009; 32(3):191-200. DOI: 10.1016/j.braindev.2009.01.004. View